Percheron Therapeutics (ASX: PER)

Last close As at 12/08/2025

AUD0.01

0.00 (11.11%)

Market capitalisation

AUD10m

Percheron Therapeutics is an international biotechnology company focused on the development of novel therapies for oncology and rare diseases.

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Dr James Garner

    Managing Director & CEO

  • Ms Deborah Ambrosini

    CFO and Company Secretary

Thematics

thematic

Healthcare

Healthcare-focused trusts: A sector on the mend

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free